enow.com Web Search

  1. Ads

    related to: alzheimer's wandering devices disease treatment

Search results

  1. Results from the WOW.Com Content Network
  2. Wandering can be deadly for the growing number of US ... - AOL

    www.aol.com/wandering-deadly-growing-number-us...

    The number of people with the disease is expected to more than double in the next 40 years, from 6.1 million patients in 2020 to around 14 million in 2060, according to the Alzheimer's Association.

  3. Wandering (dementia) - Wikipedia

    en.wikipedia.org/wiki/Wandering_(dementia)

    Although it occurs in several types of dementia, wandering is especially common in people with Alzheimer's disease (AD). People with dementia often wander because they are stressed, looking for someone or something, attending to basic needs, engaging in past routines, or with visual-spatial problems. [2] Other times, they may wander without aim ...

  4. EXCLUSIVE: Nexalin Technology Says New Data Confirms ...

    www.aol.com/exclusive-nexalin-technology-says...

    The original title incorrectly stated that the device is implantable On Monday, Nexalin Technology, Inc. (NASDAQ:NXL) announced the publication of a study in the Journal of Alzheimer’s Disease.

  5. Alzheimer's researchers say brain stimulation device ... - AOL

    www.aol.com/alzheimers-researchers-brain...

    The new study, a phase 2 clinical trial, included 32 volunteers with Alzheimer’s disease, aged 56 to 88 at the start of the study, who were followed for 52 weeks. Sixteen of the participants who ...

  6. Anti-amyloid drugs - Wikipedia

    en.wikipedia.org/wiki/Anti-amyloid_drugs

    Aducanumab, sold under the brand name Aduhelm, is a monoclonal antibody designed to treat Alzheimer's disease. It is a monoclonal antibody that targets aggregated forms (plaque) of amyloid beta (Aβ) found in the brains of people with Alzheimer's disease to reduce its buildup. [10] It was developed by Biogen and Eisai. [11] Aducanumab is given via intravenous infusion. [5] Aducanumab was ...

  7. Sundowning - Wikipedia

    en.wikipedia.org/wiki/Sundowning

    Sundowning, or sundown syndrome, [1] is a neurological phenomenon wherein people with delirium or some form of dementia experience increased confusion and restlessness beginning in the late afternoon and early evening. It is most commonly associated with Alzheimer's disease but is also found in those

  1. Ads

    related to: alzheimer's wandering devices disease treatment